Prof. Dr. med. Pietro Vernazza
Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study
Vo T, Weber R, Vernazza P, Bernasconi E, Cavassini M, Battegay M, Furrer H, Hirschel B, Keiser O, Ledergerber B, Swiss HIV Cohort Study. Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study. The Journal of infectious diseases 2008; 197:1685-94.
Jun 15, 2008Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study
Jun 15, 2008The Journal of infectious diseases 2008; 197:1685-94
Vo Thi Tuyet Nhung, Weber Rainer, Vernazza Pietro, Bernasconi Enos, Cavassini Matthias, Battegay Manuel, Furrer Hansjakob, Hirschel Bernard, Keiser Olivia, Ledergerber Bruno, Swiss HIV Cohort Study
Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era
El Amari E, Hirschel B, Bernasconi E, Hirsch H, Vernazza P, Cavassini M, Furrer H, Mueller N, Erb P, Steffen I, Cathomas G, Baumann M, Gayet-Ageron A, Toutous-Trellu L, Swiss HIV Cohort Study. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era. AIDS (London, England) 2008; 22:1019-28.
May 31, 2008Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era
May 31, 2008AIDS (London, England) 2008; 22:1019-28
El Amari Emmanuelle Boffi, Hirschel Bernard, Bernasconi Enos, Hirsch Hans H, Vernazza Pietro, Cavassini Matthias, Furrer Hansjakob, Mueller Nicolas J, Erb Peter, Steffen Ingrid, Cathomas Gieri, Baumann Michele, Gayet-Ageron Angèle, Toutous-Trellu Laurence, Swiss HIV Cohort Study
Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir
von Wyl V, Günthard H, Ledergerber B, Rickenbach M, Vernazza P, Hirschel B, Furrer H, Cavassini M, Bernasconi E, Battegay M, Klimkait T, Bürgisser P, Böni J, Yerly S, Swiss HIV Cohort Study. Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008; 46:1299-309.
Apr 15, 2008Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir
Apr 15, 2008Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008; 46:1299-309
von Wyl Viktor, Günthard Huldrych F, Ledergerber Bruno, Rickenbach Martin, Vernazza Pietro, Hirschel Bernard, Furrer Hansjakob, Cavassini Matthias, Bernasconi Enos, Battegay Manuel, Klimkait Thomas, Bürgisser Philippe, Böni Jürg, Yerly Sabine, Swiss HIV Cohort Study
Effects of cognitive behavioral stress management on HIV-1 RNA, CD4 cell counts and psychosocial parameters of HIV-infected persons
Berger S, Weber R, Battegay M, Ledergerber B, Vernazza P, Regli D, Furrer H, Zellweger C, Ehlert U, von Wyl V, Schad T, Gaab J. Effects of cognitive behavioral stress management on HIV-1 RNA, CD4 cell counts and psychosocial parameters of HIV-infected persons. AIDS (London, England) 2008; 22:767-75.
Mar 30, 2008Effects of cognitive behavioral stress management on HIV-1 RNA, CD4 cell counts and psychosocial parameters of HIV-infected persons
Mar 30, 2008AIDS (London, England) 2008; 22:767-75
Berger Simona, Weber Rainer, Battegay Manuel, Ledergerber Bruno, Vernazza Pietro, Regli Daniel, Furrer Hansjakob, Zellweger Claudine, Ehlert Ulrike, von Wyl Viktor, Schad Tanja, Gaab Jens
HAART improves quality of life: should we care about the quality of spermatozoa?
Vernazza P. HAART improves quality of life: should we care about the quality of spermatozoa?. AIDS (London, England) 2008; 22:647-8.
Mar 12, 2008HAART improves quality of life: should we care about the quality of spermatozoa?
Mar 12, 2008AIDS (London, England) 2008; 22:647-8
Vernazza Pietro
Detection of drug-resistant HIV minorities in clinical specimens and therapy failure
Louvel S, Battegay M, Vernazza P, Bregenzer T, Klimkait T, Hamy F, Swiss HIV Cohort Study. Detection of drug-resistant HIV minorities in clinical specimens and therapy failure. HIV medicine 2008; 9:133-41.
Mar 1, 2008Detection of drug-resistant HIV minorities in clinical specimens and therapy failure
Mar 1, 2008HIV medicine 2008; 9:133-41
Louvel S, Battegay M, Vernazza Pietro, Bregenzer T, Klimkait T, Hamy F, Swiss HIV Cohort Study
Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients
Glass T, Bucher H, Weber R, Rickenboch M, Bernasconi E, Vernazza P, Covassini M, Furrer H, Battegay M, Hirschel B, De Geest S, Swiss HIV Cohort Study. Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients. Antiviral therapy 2008; 13:77-85.
Jan 1, 2008Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients
Jan 1, 2008Antiviral therapy 2008; 13:77-85
Glass Tracy R, Bucher Heiner C, Weber Rainer, Rickenboch Martin, Bernasconi Enos, Vernazza Pietro, Covassini Matthias, Furrer Hansjakob, Battegay Manuel, Hirschel Bernard, De Geest Sabina, Swiss HIV Cohort Study
HIV transmission hunting--the chase for low risk events
Vernazza P, Hirschel B. HIV transmission hunting--the chase for low risk events. Antiviral therapy 2008; 13:641-2.
Jan 1, 2008HIV transmission hunting--the chase for low risk events
Jan 1, 2008Antiviral therapy 2008; 13:641-2
Vernazza Pietro, Hirschel Bernard
Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study
Fux C, Furrer H, Elzi L, Bernasconi E, Cavassini M, Vernazza P, Opravil M, Hirschel B, Bucher H, Simcock M, Rauch A, Swiss HIV Cohort Study. Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study. Antiviral therapy 2008; 13:1077-82.
Jan 1, 2008Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study
Jan 1, 2008Antiviral therapy 2008; 13:1077-82
Fux Christoph A, Furrer Hansjakob, Elzi Luigia, Bernasconi Enos, Cavassini Matthias, Vernazza Pietro, Opravil Milos, Hirschel Bernard, Bucher Heiner C, Simcock Mathew, Rauch Andri, Swiss HIV Cohort Study
Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation
Schüpbach J, Daneel S, Staub R, Güntert B, Martinetti G, Andreutti C, Steffen I, Schultze D, Dubs R, Gorgievski M, Matter L, Bürgisser P, Yerly S, Niederhauser C, Tomasik Z, Gebhardt M, Vernazza P. Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation. PLoS medicine 2007; 4:e343.
Dec 1, 2007Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation
Dec 1, 2007PLoS medicine 2007; 4:e343
Schüpbach Jörg, Daneel Synove, Staub Roger, Güntert Bruno, Martinetti Gladys, Andreutti Corinne, Steffen Ingrid, Schultze Detlev, Dubs Rolf, Gorgievski Meri, Matter Lukas, Bürgisser Philippe, Yerly Sabine, Niederhauser Christoph, Tomasik Zuzana, Gebhardt Martin D, Vernazza Pietro
[Influenza in history to the Spanish influenza]
Vernazza P. [Influenza in history to the Spanish influenza]. Therapeutische Umschau. Revue thérapeutique 2007; 64:605-7.
Nov 1, 2007[Influenza in history to the Spanish influenza]
Nov 1, 2007Therapeutische Umschau. Revue thérapeutique 2007; 64:605-7
Vernazza Pietro
[Influenza]
Vernazza P. [Influenza]. Therapeutische Umschau. Revue thérapeutique 2007; 64:603-4.
Nov 1, 2007[Influenza]
Nov 1, 2007Therapeutische Umschau. Revue thérapeutique 2007; 64:603-4
Vernazza Pietro
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study
Wolbers M, Bucher H, Günthard H, Yerly S, Battegay M, Bernasconi E, Vernazza P, Cavassini M, Furrer H, Hirschel B, von Wyl V, Opravil M, Swiss HIV Cohort Study. Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study. AIDS (London, England) 2007; 21:2201-7.
Oct 18, 2007Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study
Oct 18, 2007AIDS (London, England) 2007; 21:2201-7
Wolbers Marcel, Bucher Heiner C, Günthard Huldrych, Yerly Sabine, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Cavassini Matthias, Furrer Hansjakob, Hirschel Bernard, von Wyl Viktor, Opravil Milos, Swiss HIV Cohort Study
Establishing the safety profile of sperm washing followed by ART for the treatment of HIV discordant couples wishing to conceive
Semprini A, Bujan L, Englert Y, Smith C, Guibert J, Hollander L, Ohl J, Vernazza P. Establishing the safety profile of sperm washing followed by ART for the treatment of HIV discordant couples wishing to conceive. Human reproduction (Oxford, England) 2007; 22:2793-4; author reply 2794-5.
Oct 1, 2007Establishing the safety profile of sperm washing followed by ART for the treatment of HIV discordant couples wishing to conceive
Oct 1, 2007Human reproduction (Oxford, England) 2007; 22:2793-4; author reply 2794-5
Semprini A E, Bujan L, Englert Y, Smith C Gilling, Guibert J, Hollander L, Ohl J, Vernazza Pietro
Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network
Bujan L, Semprini A, Englert Y, Weigel M, Ohl J, Vernazza P, Guibert J, Vucetich A, Gilling-Smith C, Coudert M, Hollander L, CREAThE network. Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network. AIDS (London, England) 2007; 21:1909-14.
Sep 12, 2007Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network
Sep 12, 2007AIDS (London, England) 2007; 21:1909-14
Bujan Louis, Semprini Augusto E, Englert Yvon, Weigel Michael, Ohl Jeanine, Vernazza Pietro, Guibert Juliette, Vucetich Alexandra, Gilling-Smith Carole, Coudert Mathieu, Hollander Lital, CREAThE network
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types
von Wyl V, Günthard H, Ledergerber B, Perrin L, Rickenbach M, Bernasconi E, Vernazza P, Hirschel B, Telenti A, Furrer H, Battegay M, Klimkait T, Bürgisser P, Böni J, Yerly S, for the Swiss HIV Cohort Study. Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. Archives of internal medicine 2007; 167:1782-90.
Sep 10, 2007Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types
Sep 10, 2007Archives of internal medicine 2007; 167:1782-90
von Wyl Viktor, Günthard Huldrych F, Ledergerber Bruno, Perrin Luc, Rickenbach Martin, Bernasconi Enos, Vernazza Pietro, Hirschel Bernard, Telenti Amalio, Furrer Hansjakob, Battegay Manuel, Klimkait Thomas, Bürgisser Philippe, Böni Jürg, Yerly Sabine, for the Swiss HIV Cohort Study
Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy
Arnedo M, Tarr P, Telenti A, Beckmann J, Bergmann S, Darioli R, Bernasconi E, Vernazza P, Weber R, Elzi L, Hirschel B, Furrer H, Sahli R, Taffé P, Swiss HIV Cohort Study. Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy. Pharmacogenetics and genomics 2007; 17:755-64.
Sep 1, 2007Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy
Sep 1, 2007Pharmacogenetics and genomics 2007; 17:755-64
Arnedo Mireia, Tarr Philip E, Telenti Amalio, Beckmann Jacques S, Bergmann Sven, Darioli Roger, Bernasconi Enos, Vernazza Pietro, Weber Rainer, Elzi Luigia, Hirschel Bernard, Furrer Hansjakob, Sahli Roland, Taffé Patrick, Swiss HIV Cohort Study
The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial
Vernazza P, Daneel S, Schiffer V, Decosterd L, Fierz W, Klimkait T, Hoffmann M, Hirschel B. The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial. AIDS (London, England) 2007; 21:1309-15.
Jun 19, 2007The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial
Jun 19, 2007AIDS (London, England) 2007; 21:1309-15
Vernazza Pietro, Daneel Synove, Schiffer Véronique, Decosterd Laurent, Fierz Walter, Klimkait Thomas, Hoffmann Matthias, Hirschel Bernard
Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study
Glass T, Bucher H, Battegay M, Hirschel B, Cavassini M, Bernasconi E, Furrer H, Rickenbach M, Vernazza P, Weber R, Swiss HIV Cohort Study. Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study. HIV clinical trials 2007; 8:77-85.
Mar 1, 2007Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study
Mar 1, 2007HIV clinical trials 2007; 8:77-85
Glass Tracy R, Bucher Heiner C, Battegay Manuel, Hirschel Bernard, Cavassini Matthias, Bernasconi Enos, Furrer Hansjakob, Rickenbach Martin, Vernazza Pietro, Weber Rainer, Swiss HIV Cohort Study
Conventional tuberculin skin testing versus T-cell-based assays in the diagnosis of latent tuberculosis infection in HIV-positive patients
Hoffmann M, Reichmuth M, Fantelli K, Schoch O, Fierz W, Furrer H, Vernazza P. Conventional tuberculin skin testing versus T-cell-based assays in the diagnosis of latent tuberculosis infection in HIV-positive patients. AIDS (London, England) 2007; 21:390-2.
Jan 30, 2007Conventional tuberculin skin testing versus T-cell-based assays in the diagnosis of latent tuberculosis infection in HIV-positive patients
Jan 30, 2007AIDS (London, England) 2007; 21:390-2
Hoffmann Matthias, Reichmuth Markus, Fantelli Karin, Schoch Otto, Fierz Walter, Furrer Hansjörg, Vernazza Pietro